Navigation Links
FDA Designates MST-188 As An Orphan Drug For Treatment Of Acute Limb Ischemia
Date:11/13/2013

SAN DIEGO, Nov. 13, 2013 /PRNewswire/ -- Mast Therapeutics, Inc. (NYSE MKT: MSTX) today announced that the U.S. Food and Drug Administration (FDA) has designated MST-188 for the treatment of acute limb ischemia as an orphan drug. 

Brian M. Culley, Chief Executive Officer, said: "This designation represents further progress in our development of MST‑188 as an adjunct therapy for life-threatening conditions treated with existing thrombolytic agents, such as tPA.  As we previously reported, we are on track to initiate a phase 2, clinical proof-of-concept study in acute limb ischemia in early 2014.  If this study demonstrates that MST-188 improves the 'clot busting' activity of tPA in acute limb ischemia, we believe it would provide the data to design a registrational phase 3 study in that orphan disease, as well as generate data to support development in indications with even larger market opportunities, such as stroke." 

About Mast Therapeutics

Mast Therapeutics, Inc. is a publicly traded biopharmaceutical company headquartered in San Diego, California.  The Company is leveraging the MAST (Molecular Adhesion and Sealant Technology) platform, derived from over two decades of clinical, nonclinical and manufacturing experience with purified and non-purified poloxamers, to develop MST-188, its lead product candidate, for serious or life-threatening diseases with significant unmet needs.  MST-188 is a cytoprotective, hemorheologic, anti-inflammatory and anti-thrombotic agent that has potential utility in diseases or conditions characterized by microcirculatory insufficiency (endothelial dysfunction and/or impaired blood flow). 

The Company is enrolling subjects in EPIC, a pivotal phase 3 study of MST-188 in sickle cell disease, a genetic blood disorder in which sickled cell
'/>"/>

SOURCE Mast Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. European Commission Designates MST-188 As An Orphan Medicinal Product
2. Mast Therapeutics Presents MST-188 Data at 7Th Annual Sickle Cell Disease Research and Educational Symposium
3. Mast Therapeutics Engages ESC Advisors To Identify Partnering Opportunities For MST-188
4. U.S. FDA Grants Orphan Drug Designation for KaloBios KB001-A in Treatment of Cystic Fibrosis Patients
5. FDA Grants Orphan Drug Designation to Omeros OMS824 for Huntingtons Disease
6. Lumena Pharmaceuticals Receives Orphan Drug Designation from US Food & Drug Administration for LUM001 in Four Rare Liver Diseases
7. Bayers Investigational Drug Riociguat Granted FDA Orphan Drug Designation for Treatment of Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension
8. NovelMed Awarded NIH Fast Track SBIR Grant for $1.43 Million to Advance Development of its Anti-Complement Antibody for Orphan Disease
9. Orphan Drugs for Cancer: R&D and Market 2013-2023
10. Epizyme Receives Orphan Drug Designation for EPZ-5676
11. FDA Grants Orphan Drug Status To Eisais Investigational Compound (E7777) For Cutaneous T-Cell Lymphoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... April 21, 2015  St. Vincent Healthcare is ... care. Already following strict disinfection routines, St. Vincent ... to eliminate harmful germs, like Ebola, methicillin-resistant ... that can infect patients during their hospital stay. ... Logo - http://photos.prnewswire.com/prnh/20150420/199749LOGO ...
(Date:4/21/2015)... , April 21, 2015   iRhythm Technologies, ... the advancement of cardiac care, announced today that Banner ... in the U.S., will now be offering iRhythm,s ZIO ... continuous cardiac monitoring. "At Banner Health, we ... patient outcomes and services," said John Hensing , ...
(Date:4/21/2015)... 21, 2015 Workers, compensation pharmacy spending increased ... in utilization helped offset a 7 percent increase in ... today by Express Scripts (NASDAQ: ESRX ). ... Trend Report discusses the overall pharmacy trend as well ... Opioid Management Mitigates Spend Increases ...
Breaking Medicine Technology:St. Vincent Healthcare Deploys Germ-Killing Robot to Prevent Infection, Protect Patients During Hospital Visits 2St. Vincent Healthcare Deploys Germ-Killing Robot to Prevent Infection, Protect Patients During Hospital Visits 3Banner Health to Offer iRhythm ZIO Service for Continuous Cardiac Monitoring 2Banner Health to Offer iRhythm ZIO Service for Continuous Cardiac Monitoring 3Workers' Compensation Prescription Drug Spend Increased 1.9 Percent in 2014, Stabilized by Effective Utilization Management Programs 2Workers' Compensation Prescription Drug Spend Increased 1.9 Percent in 2014, Stabilized by Effective Utilization Management Programs 3Workers' Compensation Prescription Drug Spend Increased 1.9 Percent in 2014, Stabilized by Effective Utilization Management Programs 4
... 10, 2011 ThermoGenesis Corp. (Nasdaq: KOOL ... that process and store adult stem cells, said today ... Biotechnology Co., Ltd ("Beike"), a leading stem cell and ... agreement, ThermoGenesis will supply Beike with an initial stocking ...
... The Consumer Healthcare Products Association (CHPA) is pleased to ... Act, introduced today by Senator Kay Bailey Hutchison (R-Tex.) ... repeal a requirement enacted into law as part of ... that requires consumers to obtain a prescription in order ...
Cached Medicine Technology:ThermoGenesis Announces Agreement for AXP and BioArchive Cord Blood Systems With Major Chinese Stem Cell Company 2ThermoGenesis Announces Agreement for AXP and BioArchive Cord Blood Systems With Major Chinese Stem Cell Company 3ThermoGenesis Announces Agreement for AXP and BioArchive Cord Blood Systems With Major Chinese Stem Cell Company 4CHPA Applauds Introduction of The Patients' Freedom to Choose Act 2
(Date:4/21/2015)... QuickMedical, a veteran-owned leader in the ... Schiller America's line of Ambulatory and ... Vital Signs Monitors, among many other items. ... leader in the development and production of cardio-pulmonary ... cooperation with the world's leading physicians and specialists ...
(Date:4/21/2015)... Respected academic institution selects Visage 7 for ... Imaging Inc. (“Visage”), a wholly owned subsidiary of Pro ... contract with University of Florida Health — a large ... furthers the penetration of Visage 7 technology ... the North American enterprise imaging market. Visage 7 ...
(Date:4/21/2015)... 21, 2015 Approximately 75 million Americans ... U.S. Environmental Protection Agency (EPA). On top of this, ... smoke increase the level of toxins found in the ... these harmful toxins is to increase consumption of broccoli. ... highest level of glucoraphanin – a long-lasting antioxidant – ...
(Date:4/21/2015)... 21, 2015 Health Advocate™, Inc., the ... subsidiary of West Corporation, is hosting a complimentary webinar ... and the benefits of offering this service to employees. ... for managing their healthcare, it is critical that they ... effectively utilize their health benefits. Health advocates can play ...
(Date:4/21/2015)... Le Petit Retreat Day Spa in L.A. is no ... leafy, historic Larchmont neighborhood, newly renamed as the Larchmont Sanctuary ... “Disconnect to Reconnect.” Tina Figueroa, a former tech exec ... announces the new name and new vision for the spa, ... celebrate connections with Moms and their adult children. , ...
Breaking Medicine News(10 mins):Health News:QuickMedical Launches New Product Line: Schiller America 2Health News:QuickMedical Launches New Product Line: Schiller America 3Health News:Visage Imaging Signs University of Florida Health 2Health News:Visage Imaging Signs University of Florida Health 3Health News:Visage Imaging Signs University of Florida Health 4Health News:New Survey Shows Americans Are Cooking the Health Out of Broccoli 2Health News:New Survey Shows Americans Are Cooking the Health Out of Broccoli 3Health News:Health Advocate Webinar Discusses Benefits of Health Advocacy 2Health News:Larchmont Sanctuary Spa Revealed as New Name For Neighborhood Spa; New Owner, New Eco Offerings & New Theme: “Disconnect to Reconnect” 2Health News:Larchmont Sanctuary Spa Revealed as New Name For Neighborhood Spa; New Owner, New Eco Offerings & New Theme: “Disconnect to Reconnect” 3
... on First-line ART; Advocates Press,for Second-line Access, ... is,being issued by AIDS Healthcare Foundation (AHF):, ... improve access to lifesaving,AIDS treatments worldwide, AIDS Healthcare ... India as AHF/India Cares, and a broad-based,coalition of ...
... - No Human Vaccine Currently Exists Against the West ... in the US so far in 2007;,Collaboration Aims to ... Rapidly as Possible Acambis plc (Acambis) (LSE: ACM), ... signed an exclusive global,collaboration agreement with Sanofi Pasteur, the ...
... carbohydrates may help stunt the growth of prostate tumors, according ... The study, in mice, suggests that a reduction in insulin ... , This study showed that cutting carbohydrates may slow tumor ... urologist at Duke University Medical Center and lead researcher on ...
... 12 Beckman Coulter,Inc. (NYSE: BEC ), ... simplify, automate, and innovate complex biomedical testing,announced today ... chief financial officer, will present at the 2007 ... 2007, at,11:00 a.m. (ET). (Logo: http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO ...
... NightHawk,Radiology Holdings, Inc. (Nasdaq: NHWK ), the ... hospitals throughout the United States,today announced that it ... Conference, November 28, 2007, at 2:30 p.m. EST ... Mayleben, President and Chief Operating,Officer, and Glenn Cole, ...
... Nov. 12 IRIDEX,Corporation (Nasdaq: IRIX ) today ... results after the market closes on Monday, November,19, 2007. ... a,conference call with the investment community at 5:00 p.m. ... results of the quarter and other,business developments. Interested ...
Cached Medicine News:Health News:Activist Groups' Plea to Indian Prime Minister: 'Rollout Second-Line AIDS Treatment!' 2Health News:Activist Groups' Plea to Indian Prime Minister: 'Rollout Second-Line AIDS Treatment!' 3Health News:Activist Groups' Plea to Indian Prime Minister: 'Rollout Second-Line AIDS Treatment!' 4Health News:Activist Groups' Plea to Indian Prime Minister: 'Rollout Second-Line AIDS Treatment!' 5Health News:Acambis Joins Forces With Sanofi Pasteur to Develop West Nile Virus Vaccine 2Health News:Acambis Joins Forces With Sanofi Pasteur to Develop West Nile Virus Vaccine 3Health News:Acambis Joins Forces With Sanofi Pasteur to Develop West Nile Virus Vaccine 4Health News:A low-carb diet may stunt prostate tumor growth 2Health News:Beckman Coulter to Present at the Credit Suisse Global Healthcare Conference 2Health News:NightHawk Radiology Holdings, Inc. to Speak at Annual Piper Jaffray Healthcare Conference on November 28, 2007 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: